CHI's Biological Safety Issues
	Cambridge Healthtech Institute (CHI) , Washington, DC October 28-29, 1999
	Removal of foreign agents such as chemical contaminants, bacteria, viruses, trace DNA and endotoxins from biologics is a difficult and complex problem, yet it is critical to the safety of therapeutics and diagnostics utilizing any human or animal sera or cells. If your work involves the production or use of antibodies, gene therapies/gene therapy vectors, cell cultures, bovine serum or cells, human cells or serum, or bioreactors, this conference will provide the latest information to help you guarantee the safety of these products.
	Organized by:	CHI
	Deadline for Abstracts:	September 17,1999
	Registration:	For more details and to register on-line, please go to our website.
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: wks137.healthtech.com date: June 11, 1999 20:15:39 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.